BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28702410)

  • 1. Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India.
    Rudresha AH; Lakshmaiah KC; Agarwal A; Babu KG; Loknatha D; Jacob LA; Babu S; Lokesh KN; Rajeev LK
    South Asian J Cancer; 2017; 6(2):69-71. PubMed ID: 28702410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
    Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
    Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
    Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
    Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review.
    Cao C; Liu T; Lou S; Liu W; Shen K; Xiang B
    Oncol Lett; 2014 Dec; 8(6):2539-2542. PubMed ID: 25364423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
    Mai B; Wang W; Lin M; Hu S; Wang XI; Chen L; Wahed A; Nguyen A; Ma HY; Medeiros LJ; Hu Z
    AIDS; 2020 Oct; 34(12):1735-1743. PubMed ID: 32889849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological Characteristics and Prognosis Analysis of the Patients with Plasmablastic Lymphoma].
    Feng J; Xu L; Dong HJ; Zhang N; Bai QX; Liang R; Shu MM; Yang L; Chen XQ; Gu HT; Gao GX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1350-1354. PubMed ID: 30295249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis.
    Han X; Duan M; Hu L; Zhou D; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(9):e5981. PubMed ID: 28248855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].
    Han X; Hu LX; Ouyang MQ; Duan MH; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):290-294. PubMed ID: 28468089
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
    Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
    Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
    Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
    Leuk Lymphoma; 2010 Nov; 51(11):2047-53. PubMed ID: 20919850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis.
    Komaranchath AS; Haleshappa RA; Kuntegowdenahalli LC; Kumar RV; Dasappa L; Babu G
    Indian J Cancer; 2016; 53(4):529-533. PubMed ID: 28485344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-negative plasmablastic lymphoma: not in the mouth.
    Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin GA; Butera JN
    Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):185-9. PubMed ID: 21575922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablastic Lymphoma: A Clinicopathological Study from a Tertiary Care Cancer Center in South India.
    Mundada MC; Ahmed F; Khera R; Murthy S; Rajappa S; Santa A; Mallavarapu K
    South Asian J Cancer; 2020 Jun; 9(2):105-108. PubMed ID: 33354553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.